Week 5 - UC + CD + Pharmaceutical Care Flashcards
1
Q
What infections are higher risk for IBD patients?
A
- Enteric infections
E. coli
C difficle
Norovirus
2
Q
What immunosuppressive therapy is provided to prevent infection ?
A
At diagnosis the following immunotherpaies are checked for
- Infection history - HSV / VZV ( chicken pox/ shingles)
- ## Immunisation status
2
Q
What pharmacuetical issues are related to corticosteroids >
A
- When taking patient off then a reducing dose course must be completed
- dependence can biuld
- prolongwd use can lead to increased risk of CVD oesteoarthiritis , diabetes & weight gain
3
Q
what monitoring paraments should done in regard to issues concerning corticosteroids ?
A
Lipid levels
Glucose levels
mood
BP
4
Q
Why should bone health be monitored along side IBD ?and which patients groups should be monitored ?and what shld they be given ?
A
- IBD patient have an increased of developing oesteoarthiritis
- RIsk factors- uncontrolled inflammation , malabsorption , weight loss
- Patients on corticosteroids -
- 800mg-1000mg calcium
- 800 IU vitamin D daily
If patient is high risk - bisphosphates ( alendronate, risedronate)
5
Q
What other monitoring therpaies should be done
A
HB
nutrition absorption
